---
figid: PMC3132850__neo1307_0643_fig006
figlink: /pmc/articles/PMC3132850/figure/F6/
number: Figure 6
caption: Model of functional inactivation of merlin by two-step phosphorylation. Under
  growth-inhibitory conditions, unphosphorylated functionally active merlin is in
  a closed conformation. On growth factor signaling, either PKA or PAK phosphorylates
  serine 518, leading to a more open conformation. At this conformation, merlin is
  susceptible to Akt- or PKA-mediated phosphorylation of serine 10, which subsequently
  triggers degradation and inactivation of merlin through the proteasome pathway.
pmcid: PMC3132850
papertitle: Multistep Phosphorylation by Oncogenic Kinases Enhances the Degradation
  of the NF2 Tumor Suppressor Merlin.
reftext: Minja Laulajainen, et al. Neoplasia. 2011 Jul;13(7):643-652.
pmc_ranked_result_index: '86379'
pathway_score: 0.9606748
filename: neo1307_0643_fig006.jpg
figtitle: Functional inactivation of merlin by two-step phosphorylation
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3132850__neo1307_0643_fig006.html
  '@type': Dataset
  description: Model of functional inactivation of merlin by two-step phosphorylation.
    Under growth-inhibitory conditions, unphosphorylated functionally active merlin
    is in a closed conformation. On growth factor signaling, either PKA or PAK phosphorylates
    serine 518, leading to a more open conformation. At this conformation, merlin
    is susceptible to Akt- or PKA-mediated phosphorylation of serine 10, which subsequently
    triggers degradation and inactivation of merlin through the proteasome pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAR1A
  - PRKAR1B
  - AKT1
  - AKT3
  - PAK6
  - PRKACG
  - PRKACA
  - PRKACB
  - PAK1
  - PAK3
  - PRKAR2B
  - PAK5
  - PAK2
  - AKT2
  - PRKAR2A
  - PAK4
genes:
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: AKT/
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT/
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: AKT/
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
chemicals: []
diseases: []
---
